视角:阻塞性睡眠呼吸暂停的系统审查和元分析 - - 缺少什么?
Daniil Lisik1, Gabriel Natan Pires2, Ding Zou3
1Krefting Research Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
Sleep medicine
|September 17, 2023
概括
阻塞性睡眠呼吸暂停 (OSA) 影响全球健康,目前的治疗方法,如正气道压力 (PAP) 疗法,显示出局限性. 新的研究探讨了替代疗法,强调了需要更好的证据综合.
科学领域:
- 睡眠医学 睡眠医学
- 呼吸系统医学 呼吸系统医学
- 心血管健康 心血管健康
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 影响全球近10亿成年人,严重影响生活质量,认知和心血管健康.
- 阳性气道压力 (PAP) 治疗,标准的第一线治疗,面临的挑战是患者的遵从性和长期心血管结果的有效性.
- 对新型非PAP治疗方法的新兴研究是由对OSA病原体的更深入理解所驱动的.
研究的目的:
- 解决对新兴阻塞性睡眠呼吸暂停 (OSA) 治疗的高质量证据综合的关键需求.
- 批判性地评估OSA领域现有的系统性审查和元分析 (SR/MA) 的方法限制.
- 讨论OSA管理当前的挑战,并提出未来的观点,包括一种可治疗的基于特征的方法.
主要方法:
- 审查和分析关于阻塞性睡眠呼吸暂停 (OSA) 管理和新治疗方法的当前文献.
- 对现有的系统性审查和元分析 (SR/MA) 进行批判性评估,以确定其方法论的严谨性和相关性.
- 讨论OSA的病原性,可治疗的特征,以及当前证据合成的局限性.
主要成果:
- 目前关于非PAP OSA治疗的系统性审查和元分析 (SR / MA) 经常表现出方法上的限制.
- 在SR/MA中现有的研究问题可能无法完全捕捉到OSA管理的复杂性.
- 有越来越多的证据表明,除了PAP之外,有前途的新型治疗策略.
结论:
- 阻塞性睡眠呼吸暂停 (OSA) 的有效管理需要解决当前治疗遵守和长期结果的局限性.
- 基于可治疗特征的OSA管理方法有望为个性化和有效的治疗策略提供希望.
- 未来的研究和高质量的证据合成对于指导新型OSA治疗的开发和实施至关重要.
相关概念视频
Sleep Apnea
184
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
184
Insufficient Sleep and Sleep Deprivation
167
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
167
Other Pulmonary Disorders
869
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
869
Respiratory Assessment: Purpose and Indications
1.1K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Acute Respiratory Failure-II
269
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
269


